Global Oral Proteins and Peptides Market Research Report 2023(Status and Outlook)
Report Overview
Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.
The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.
The Global Oral Proteins and Peptides Market Size was estimated at USD 751.80 million in 2022 and is projected to reach USD 1175.99 million by 2029, exhibiting a CAGR of 6.60% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Oral Proteins and Peptides market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oral Proteins and Peptides Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oral Proteins and Peptides market in any manner.
Global Oral Proteins and Peptides Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Allergan
AstraZeneca
Biocon
Generex Biotechnology
Novo Nordisk
Synergy Pharmaceuticals
Tarsa Therapeutics
Sanofi
Hoffmann-La Roche
Synthetic Biologics
Hovione
Novartis
Market Segmentation (by Type)
Linaclotide
Calcitonin
Insulin
Octreotide
Market Segmentation (by Application)
Bonded Marine Oil
Domestic Trade Marine Oil
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oral Proteins and Peptides Market
Overview of the regional outlook of the Oral Proteins and Peptides Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Oral Proteins and Peptides
- 1.2 Key Market Segments
- 1.2.1 Oral Proteins and Peptides Segment by Type
- 1.2.2 Oral Proteins and Peptides Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Oral Proteins and Peptides Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Oral Proteins and Peptides Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Oral Proteins and Peptides Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Oral Proteins and Peptides Market Competitive Landscape
- 3.1 Global Oral Proteins and Peptides Sales by Manufacturers (2018-2023)
- 3.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Oral Proteins and Peptides Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Oral Proteins and Peptides Sales Sites, Area Served, Product Type
- 3.6 Oral Proteins and Peptides Market Competitive Situation and Trends
- 3.6.1 Oral Proteins and Peptides Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Oral Proteins and Peptides Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Oral Proteins and Peptides Industry Chain Analysis
- 4.1 Oral Proteins and Peptides Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Oral Proteins and Peptides Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Oral Proteins and Peptides Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Oral Proteins and Peptides Sales Market Share by Type (2018-2023)
- 6.3 Global Oral Proteins and Peptides Market Size Market Share by Type (2018-2023)
- 6.4 Global Oral Proteins and Peptides Price by Type (2018-2023)
- 7 Oral Proteins and Peptides Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Oral Proteins and Peptides Market Sales by Application (2018-2023)
- 7.3 Global Oral Proteins and Peptides Market Size (M USD) by Application (2018-2023)
- 7.4 Global Oral Proteins and Peptides Sales Growth Rate by Application (2018-2023)
- 8 Oral Proteins and Peptides Market Segmentation by Region
- 8.1 Global Oral Proteins and Peptides Sales by Region
- 8.1.1 Global Oral Proteins and Peptides Sales by Region
- 8.1.2 Global Oral Proteins and Peptides Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Oral Proteins and Peptides Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Oral Proteins and Peptides Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Oral Proteins and Peptides Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Oral Proteins and Peptides Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Oral Proteins and Peptides Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Allergan
- 9.1.1 Allergan Oral Proteins and Peptides Basic Information
- 9.1.2 Allergan Oral Proteins and Peptides Product Overview
- 9.1.3 Allergan Oral Proteins and Peptides Product Market Performance
- 9.1.4 Allergan Business Overview
- 9.1.5 Allergan Oral Proteins and Peptides SWOT Analysis
- 9.1.6 Allergan Recent Developments
- 9.2 AstraZeneca
- 9.2.1 AstraZeneca Oral Proteins and Peptides Basic Information
- 9.2.2 AstraZeneca Oral Proteins and Peptides Product Overview
- 9.2.3 AstraZeneca Oral Proteins and Peptides Product Market Performance
- 9.2.4 AstraZeneca Business Overview
- 9.2.5 AstraZeneca Oral Proteins and Peptides SWOT Analysis
- 9.2.6 AstraZeneca Recent Developments
- 9.3 Biocon
- 9.3.1 Biocon Oral Proteins and Peptides Basic Information
- 9.3.2 Biocon Oral Proteins and Peptides Product Overview
- 9.3.3 Biocon Oral Proteins and Peptides Product Market Performance
- 9.3.4 Biocon Business Overview
- 9.3.5 Biocon Oral Proteins and Peptides SWOT Analysis
- 9.3.6 Biocon Recent Developments
- 9.4 Generex Biotechnology
- 9.4.1 Generex Biotechnology Oral Proteins and Peptides Basic Information
- 9.4.2 Generex Biotechnology Oral Proteins and Peptides Product Overview
- 9.4.3 Generex Biotechnology Oral Proteins and Peptides Product Market Performance
- 9.4.4 Generex Biotechnology Business Overview
- 9.4.5 Generex Biotechnology Oral Proteins and Peptides SWOT Analysis
- 9.4.6 Generex Biotechnology Recent Developments
- 9.5 Novo Nordisk
- 9.5.1 Novo Nordisk Oral Proteins and Peptides Basic Information
- 9.5.2 Novo Nordisk Oral Proteins and Peptides Product Overview
- 9.5.3 Novo Nordisk Oral Proteins and Peptides Product Market Performance
- 9.5.4 Novo Nordisk Business Overview
- 9.5.5 Novo Nordisk Oral Proteins and Peptides SWOT Analysis
- 9.5.6 Novo Nordisk Recent Developments
- 9.6 Synergy Pharmaceuticals
- 9.6.1 Synergy Pharmaceuticals Oral Proteins and Peptides Basic Information
- 9.6.2 Synergy Pharmaceuticals Oral Proteins and Peptides Product Overview
- 9.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Product Market Performance
- 9.6.4 Synergy Pharmaceuticals Business Overview
- 9.6.5 Synergy Pharmaceuticals Recent Developments
- 9.7 Tarsa Therapeutics
- 9.7.1 Tarsa Therapeutics Oral Proteins and Peptides Basic Information
- 9.7.2 Tarsa Therapeutics Oral Proteins and Peptides Product Overview
- 9.7.3 Tarsa Therapeutics Oral Proteins and Peptides Product Market Performance
- 9.7.4 Tarsa Therapeutics Business Overview
- 9.7.5 Tarsa Therapeutics Recent Developments
- 9.8 Sanofi
- 9.8.1 Sanofi Oral Proteins and Peptides Basic Information
- 9.8.2 Sanofi Oral Proteins and Peptides Product Overview
- 9.8.3 Sanofi Oral Proteins and Peptides Product Market Performance
- 9.8.4 Sanofi Business Overview
- 9.8.5 Sanofi Recent Developments
- 9.9 Hoffmann-La Roche
- 9.9.1 Hoffmann-La Roche Oral Proteins and Peptides Basic Information
- 9.9.2 Hoffmann-La Roche Oral Proteins and Peptides Product Overview
- 9.9.3 Hoffmann-La Roche Oral Proteins and Peptides Product Market Performance
- 9.9.4 Hoffmann-La Roche Business Overview
- 9.9.5 Hoffmann-La Roche Recent Developments
- 9.10 Synthetic Biologics
- 9.10.1 Synthetic Biologics Oral Proteins and Peptides Basic Information
- 9.10.2 Synthetic Biologics Oral Proteins and Peptides Product Overview
- 9.10.3 Synthetic Biologics Oral Proteins and Peptides Product Market Performance
- 9.10.4 Synthetic Biologics Business Overview
- 9.10.5 Synthetic Biologics Recent Developments
- 9.11 Hovione
- 9.11.1 Hovione Oral Proteins and Peptides Basic Information
- 9.11.2 Hovione Oral Proteins and Peptides Product Overview
- 9.11.3 Hovione Oral Proteins and Peptides Product Market Performance
- 9.11.4 Hovione Business Overview
- 9.11.5 Hovione Recent Developments
- 9.12 Novartis
- 9.12.1 Novartis Oral Proteins and Peptides Basic Information
- 9.12.2 Novartis Oral Proteins and Peptides Product Overview
- 9.12.3 Novartis Oral Proteins and Peptides Product Market Performance
- 9.12.4 Novartis Business Overview
- 9.12.5 Novartis Recent Developments
- 10 Oral Proteins and Peptides Market Forecast by Region
- 10.1 Global Oral Proteins and Peptides Market Size Forecast
- 10.2 Global Oral Proteins and Peptides Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Oral Proteins and Peptides Market Size Forecast by Country
- 10.2.3 Asia Pacific Oral Proteins and Peptides Market Size Forecast by Region
- 10.2.4 South America Oral Proteins and Peptides Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Oral Proteins and Peptides by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Oral Proteins and Peptides Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Oral Proteins and Peptides by Type (2024-2029)
- 11.1.2 Global Oral Proteins and Peptides Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Oral Proteins and Peptides by Type (2024-2029)
- 11.2 Global Oral Proteins and Peptides Market Forecast by Application (2024-2029)
- 11.2.1 Global Oral Proteins and Peptides Sales (K MT) Forecast by Application
- 11.2.2 Global Oral Proteins and Peptides Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook